Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities
暂无分享,去创建一个
Kazuhiro Yoshida | H. Shibata | M. Inoue | M. Miura | K. Fukuda | A. Tsuji | N. Matsuhashi | K. Shimazu | Taichi Yoshida | Daiki Taguchi | H. Okuyama | K. Fujita